T News

ENABLE (IMI) selects one of Mutabilis’ programme as new antibiotic candidate. Nov 6th 2019

By: | Tags: | Comments: 0

Following the integration of Mutabilis’ second programme in ENABLE in April 2018, the ENABLE Portfolio Management Committee has selected a candidate from this programme.

The ENABLE project is supported by the Innovative Medicines Initiative (IMI), a Public-Private Partnership jointly funded by the European Commission (EC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Download full press release

You must be logged in to post a comment.